Company Analysis LifeStance Health Group, Inc.
1. Summary
Advantages
- Price (7.46 $) is less than fair price (7.54 $)
- The stock's return over the last year (11.03%) is higher than the sector average (-22.03%).
- Current debt level 22.9% is below 100% and has decreased over 5 years from 23.1%.
Disadvantages
- Dividends (0%) are below the sector average (0.53%).
- The company's current efficiency (ROE=-4%) is lower than the sector average (ROE=104.34%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| LifeStance Health Group, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -2% | 0% | 0.9% |
| 90 days | 12.8% | -23.7% | 5.5% |
| 1 year | 11% | -22% | 22.1% |
LFST vs Sector: LifeStance Health Group, Inc. has outperformed the "Healthcare" sector by 33.05% over the past year.
LFST vs Market: LifeStance Health Group, Inc. has significantly underperformed the market by -11.03% over the past year.
Stable price: LFST is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: LFST with weekly volatility of 0.21% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (7.46 $) is lower than the fair price (7.54 $).
Price not significantly lower than the fair price: The current price (7.46 $) is slightly lower than the fair price by 1.1%.
5.2. P/E
P/E vs Sector: The company's P/E (-34.12) is lower than that of the sector as a whole (35.84).
P/E vs Market: The company's P/E (-34.12) is higher than that of the market as a whole (-65.92).
5.3. P/BV
P/BV vs Sector: The company's P/BV (1.93) is lower than that of the sector as a whole (254.49).
P/BV vs Market: The company's P/BV (1.93) is lower than that of the market as a whole (51.09).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (2.23) is lower than that of the sector as a whole (127.81).
P/S vs Market: The company's P/S indicator (2.23) is lower than that of the market as a whole (147.92).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (78.37) is higher than that of the sector as a whole (-27.35).
EV/Ebitda vs Market: The company's EV/Ebitda (78.37) is higher than that of the market as a whole (-94.27).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -16.26% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-16.26%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1802.65%).
6.4. ROE
ROE vs Sector: The company's ROE (-4%) is lower than that of the sector as a whole (104.34%).
ROE vs Market: The company's ROE (-4%) is higher than that of the market as a whole (-6.17%).
6.6. ROA
ROA vs Sector: The company's ROA (-2.64%) is lower than that of the sector as a whole (-2.2%).
ROA vs Market: The company's ROA (-2.64%) is lower than that of the market as a whole (38.35%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (-21.54%) is lower than that of the sector as a whole (1.17%).
ROIC vs Market: The company's ROIC (-21.54%) is lower than that of the market as a whole (9.59%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.53%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
9. Insider trades
9.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
9.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 18.12.2025 | Bessler Robert Director |
Purchase | 7 | 4 509 | 6 442 |
| 18.08.2025 | SUMMIT INVESTORS GE IX/VC IV ( Owner |
Purchase | 5.41 | 20 336 | 3 759 |
| 18.08.2025 | SUMMIT INVESTORS GE IX-VC IV, Owner |
Purchase | 5.41 | 194 425 | 35 938 |
| 16.06.2025 | Ramtekkar Ujjwal Officer |
Purchase | 5.17 | 49 213 | 9 519 |
| 09.04.2025 | Bessler Robert Director |
Purchase | 7.01 | 34 349 | 4 900 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
